Sort
51,593 grants matching “hepatitis”
Molecular markers of early cardiometabolic health transitions in the CARDIA study
$589,198Ravi Shah · Massachusetts General Hospital · R01 · FY2019 · HL
Environmental Factors in HIV Transmission among Suburban IDUs
$589,164Robert Heimer · Yale University · R01 · FY2008 · DA
Genetic Epidemiology of Complex Traits
$589,154Joan E. Bailey-Wilson · National Human Genome Research Institute · ZIA · FY2013 · HG
Moderately CHO-restricted diet as treatment targeting improvement in hepatic lipid and insulin sensitivity in adolescents with NAFLD
$588,998Amy Miskimon Goss · University Of Alabama At Birmingham · R01 · FY2023 · DK
Computational Models of Infectious Disease Threats
$588,968Donald S. Burke · University Of Pittsburgh At Pittsburgh · U01 · FY2007 · GM
Targeting Oncogenic PKA signaling mechanisms
$588,909John D Gordan · University Of California, San Francisco · R01 · FY2025 · CA
Dietary regulation of the hepatic epigenome
$588,860John M Denu · University Of Wisconsin-Madison · R01 · FY2021 · DK
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
$588,857John S Markowitz · University Of Florida · R01 · FY2019 · HD
Moderately CHO-restricted diet as treatment targeting improvement in hepatic lipid and insulin sensitivity in adolescents with NAFLD
$588,831Amy Miskimon Goss · University Of Alabama At Birmingham · R01 · FY2022 · DK
RNA silencing machinery in extracellular vesicle-mediated immunometabolic regulation
$588,775Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · DK
Preclinical studies of a heroin/morphine vaccine for opiate addiction
$588,744Paul Pentel · Hennepin Healthcare Research Institute · R01 · FY2010 · DA
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$588,744Joannes B Hoek · Thomas Jefferson University · R01 · FY2017 · AA
Increasing HCV Knowledge & Service Use in Drug Tx Pgms
$588,736Shiela M Strauss · National Development And Research Institutes, Inc. · R01 · FY2006 · DA
Novel Transgenic Rabbit Model for Cardiovascular Disease
$588,734Fuliang Du · Evergen Biotechnologies, Inc. · R44 · FY2009 · HL
Apolipoprotein M: a novel regulator of myocardial Autophagy
$588,733Ali Javaheri · Washington University · R01 · FY2024 · HL
Stem Cell-Based In vivo Models of Human Genetic Liver Diseases
$588,654Gary A Peltz · Stanford University · R01 · FY2015 · DK
Core--Imaging
$588,618Melvin E Clouse · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL
Systems genetics approaches to bile acid metabolisms
$588,606Karen Reue · University Of California Los Angeles · P01 · FY2015 · HL
Alcohol Reduction in Medical Illnesses:HCV as Prototype
$588,569Neal V Dawson · Case Western Reserve University · R01 · FY2006 · AA
Regulation of Lipolysis by Oxytocin
$588,562Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2022 · DK
Quality of life outcomes in prescription and injection opioid dependence
$588,560Bruce R Schackman · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · DA
At Risk Hispanic Gangs: Long-Term Consequences for Hiv, Hepatitis and STI
$588,531Avelardo Valdez · University Of Houston · R01 · FY2008 · DA
Adipsin in NASH
$588,489Utpal Pajvani · Columbia University Health Sciences · R01 · FY2023 · DK
Adipsin in NASH
$588,489Utpal Pajvani · Columbia University Health Sciences · R01 · FY2025 · DK
Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition
$588,464Celia A. Schiffer · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · AI